Back to Search
Start Over
Long-term molecular remission in Philadelphia-positive acute lymphoblastic leukemia elderly patient after dasatinib discontinuation
- Source :
- Leukemia & Lymphoma. 57:2445-2447
- Publication Year :
- 2016
- Publisher :
- Informa UK Limited, 2016.
-
Abstract
- The clinical outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) has significantly improved following targeted treatment with tyrosine-kinase inhibitors (...
- Subjects :
- Cancer Research
medicine.medical_specialty
business.industry
Lymphoblastic Leukemia
Philadelphia positive
hemic and immune systems
Hematology
humanities
Discontinuation
Dasatinib
03 medical and health sciences
0302 clinical medicine
Oncology
hemic and lymphatic diseases
030220 oncology & carcinogenesis
Internal medicine
medicine
Elderly patient
business
030215 immunology
medicine.drug
Subjects
Details
- ISSN :
- 10292403 and 10428194
- Volume :
- 57
- Database :
- OpenAIRE
- Journal :
- Leukemia & Lymphoma
- Accession number :
- edsair.doi...........798294026b32aee0311df04f25c3caeb
- Full Text :
- https://doi.org/10.3109/10428194.2016.1140163